{"name":"TherapeuticsMD","slug":"therapeuticsmd","ticker":"TXMD","exchange":"NASDAQ","domain":"therapeuticsmd.com","description":"TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.","hq":"Boca Raton, FL","founded":0,"employees":"1","ceo":"Robert G. Finizio","sector":"Women's Health / Specialty Pharma","stockPrice":2.02,"stockChange":0,"stockChangePercent":0,"marketCap":"$23M","metrics":{"revenue":3353000,"revenueGrowth":84.2,"grossMargin":100,"rdSpend":7086000,"netIncome":-2181000,"cash":8419000,"dividendYield":0,"peRatio":201.5,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-01","label":"Biodelivier patent cliff ($100M at risk)","drug":"Biodelivier","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Segesterone Acetate and Ethinyl Estradiol","genericName":"Segesterone Acetate and Ethinyl Estradiol","slug":"segesterone-acetate-and-ethinyl-estradiol","indication":"Contraception in women of reproductive potential","status":"marketed"}]}],"pipeline":[{"name":"Segesterone Acetate and Ethinyl Estradiol","genericName":"Segesterone Acetate and Ethinyl Estradiol","slug":"segesterone-acetate-and-ethinyl-estradiol","phase":"marketed","mechanism":"A progestin-estrogen combination that suppresses ovulation and alters cervical mucus and endometrial environment to prevent pregnancy.","indications":["Contraception in women of reproductive potential"],"catalyst":""}],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"TherapeuticsMD Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"TherapeuticsMD reported its fourth quarter and full year 2023 financial results, with revenue of $13.4 million and a net loss of $14.4 million.","drugName":"","sentiment":"neutral"},{"date":"2023-10-25","type":"deal","headline":"TherapeuticsMD Announces Exclusive Distribution Agreement with CVS Pharmacy","summary":"TherapeuticsMD announced an exclusive distribution agreement with CVS Pharmacy to make its products available in CVS pharmacies.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"FDA Approves Biodelivier (Segesterone Acetate and Ethinyl Estradiol) for the Prevention of Pregnancy","summary":"The FDA approved Biodelivier (Segesterone Acetate and Ethinyl Estradiol) for the prevention of pregnancy in women of reproductive age.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPTEJxOE1fRklJYkRaTWpOMWV0YXZjOHNMQndrTUtsVE5GVndLcGJNQXgxNVBXS1lFaHlSWjlOUVdGY3d4Ym81R0tsMmFiOTBuNzVEaTAzTEhueXNFQmlWMXpSYkg2R0M5T25rVDlvSnU5MjJJZnpMVHpoUVNaazZ4N0ZLOXRWVTMyaURYOFVFeGotbU9pMUNsY3dySHU3eXR2N3V2N0xSdW4wNy15NWg4Tw?oc=5","date":"2026-03-30","type":"pipeline","source":"ChartMill","summary":"TherapeuticsMD Announces Full Year 2025 Financial Results - ChartMill","headline":"TherapeuticsMD Announces Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPZVlEenlfQlJjd1VmN2ZvYkJjRFNfNXlfUEdpWkVUeGgyRmlFRUE5THJ0TmRrajBTREF6M1VUeE9MV0VLOFFIMXpFU0NGT1VZaDJKOWZTa0tma2ZtaV9ET3VtMk4zdERudW9Objhsd3liMHN0Wm8zTWZmZllENTBQUXBlNXRCb0tpc1J1Q3pYUHdlZE9YSi1GeGJVZEtKNGF0YlFuVTBxVWxOQkVq?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"TherapeuticsMD (NASDAQ: TXMD) reports 2025 results, weighs strategic options - Stock Titan","headline":"TherapeuticsMD (NASDAQ: TXMD) reports 2025 results, weighs strategic options","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: ANNUAL REPORT","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBCRXJMSDhEZ0hMdTVYSjh5Qk5tdDJ3V2pNUGZDM0hqRzdpeVBSTXRaMUloekM2WnJVMHBodWNtNklwM0ZkeWhNemRDZHlHdzBhOExJR3doRzFjWWxFOTlfblg4ZXYxTG8zUm9ST2tR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Therapeuticsmd Inc (TXMD) - Stock Titan","headline":"If You Invested $1,000 in Therapeuticsmd Inc (TXMD)","sentiment":"neutral"},{"date":"2026-01-21","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-11-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOS0VPV3V5Smc5UXNUSnh1RGRoUlFTRGtpQVBQVjNMUWJ0UnBTYkxEUi1DaUFFX0d0NDE5c1pRR1Rad1MycmtrOU9reHc4MXY0dThCcWFHMGNsTmxQNWdvbndKOEVrTEc4d0xHLXRxV0wtN0NKcGlJWWJnQVlGUlZkekZhMzFPZHVmbjBVNXJ2czhDcjQ?oc=5","date":"2025-11-12","type":"earnings","source":"Yahoo Finance","summary":"TherapeuticsMD Announces Third Quarter 2025 Financial Results - Yahoo Finance","headline":"TherapeuticsMD Announces Third Quarter 2025 Financial Results","sentiment":"neutral"},{"date":"2025-11-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-08-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOaDNuWHRfTGJ1VjlsMk5nNldDYWVPLVQ0X0lHazg5ZFlDRENEVXA5MU1TYWZvYnE3QUZaYVRlN1hZZzl3WnNvbnQ3RTRyNTRVdG1HeFFvUDlBX3dxdnkxVjZxdHNId3NEYUI3OUZHWFNoZ3JoaWVtNEYzOXFLXzNpcE02ZVAzdG00THpoUFktXy1sLW9VSERZWVZDZlJUOW8?oc=5","date":"2023-05-23","type":"pipeline","source":"Seeking Alpha","summary":"TherapeuticsMD (TXMD): From Fallen And Forgotten To Cash Cow - Seeking Alpha","headline":"TherapeuticsMD (TXMD): From Fallen And Forgotten To Cash Cow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQNVdrZUJ5X3hmUkU0bmFpbUx4VGFIM1V1RnRxdnNDMmpzVDRDVEFOTTZ6YVJhalFrUkZLN2NPMzk5LTlIVXRJUzFfUGFHbFZKZzFLbndmRmlaS2Y4b0FseGhGWXoxMEVsVGVNTXJFWFU1NnFvVTdaUmlUYXFqZEJPS2JjSTA1ZHBTTDQ5dU1URVBpNTAtRlExaEhuYW1ZeS1vbEs0MmpGUkhiQQ?oc=5","date":"2023-01-03","type":"pipeline","source":"The Business Journals","summary":"TheraputicsMD sells products rights for $153 million - The Business Journals","headline":"TheraputicsMD sells products rights for $153 million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQcHR1Mk9Wb0lEM1RTTDFmYmVzeWc3bWtpNlRqSXJNcmZyYmp6eHV3eVZrcjRSalRNdzBqczJOcklBM2FaVjEyX1FjNGpTSjZGa3ExZ1RiVXZFaGF5OHAtdERVaEhiQmlDRVIyRHBnZjMyQ2hmS2VqaFZEWlpGcmU5dWVnM2ZOdnVnc2hXMmpNOTdNRXRNeEM5b1pMdG1hRWY4SUZhcWxta0F6bEtHOU9DT0VuSEp3NTlrWlRRcg?oc=5","date":"2022-12-09","type":"pipeline","source":"Fierce Pharma","summary":"TherapeuticsMD lays off entire workforce after licensing products out for $153M - Fierce Pharma","headline":"TherapeuticsMD lays off entire workforce after licensing products out for $153M","sentiment":"neutral"}],"patents":[{"drugName":"Biodelivier","drugSlug":"segesterone-acetate-and-ethinyl-estradiol","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":100000000}],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Myovant Sciences","Mayne Pharma","Pfizer"],"therapeuticFocus":["Women's Health","Reproductive Health"],"financials":{"source":"sec_edgar+yahoo","revenue":1761000,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":1761000,"period":"2024-12-31"},{"value":1302000,"period":"2023-12-31"},{"value":1302000,"period":"2023-12-31"},{"value":69963000,"period":"2022-12-31"}],"grossProfit":1302000,"grossProfitHistory":[{"period":"2023-12-31","value":1302000},{"period":"2022-12-31","value":68566000},{"period":"2021-12-31","value":1171000}],"rdSpend":7086000,"rdSpendHistory":[{"period":"2022-12-31","value":0},{"period":"2021-12-31","value":0}],"sgaSpend":6852000,"operatingIncome":-4214000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-4214000},{"period":"2024-12-31","value":-4844000},{"period":"2023-12-31","value":-8523000},{"period":"2022-12-31","value":10663000}],"netIncome":-2181000,"netIncomeHistory":[{"period":"2025-12-31","value":-569000},{"period":"2024-12-31","value":-2181000},{"period":"2023-12-31","value":-10278000},{"period":"2022-12-31","value":111997000}],"eps":-0.19,"epsHistory":[{"period":"2024-12-31","value":-0.19},{"period":"2023-12-31","value":-0.98},{"period":"2022-12-31","value":11.96},{"period":"2021-12-31","value":-21.5}],"cash":7483000,"cashHistory":[{"period":"2025-12-31","value":7483000},{"period":"2024-12-31","value":5059000},{"period":"2023-12-31","value":4327000},{"period":"2022-12-31","value":38067000}],"totalAssets":38822000,"totalLiabilities":10780000,"totalDebt":6097000,"equity":26876000,"operatingCashflow":2454000,"operatingCashflowHistory":[{"period":"2025-12-31","value":2454000},{"period":"2024-12-31","value":1170000},{"period":"2023-12-31","value":-23081000},{"period":"2022-12-31","value":9359000}],"capex":-355000,"capexHistory":[{"period":"2022-12-31","value":-355000},{"period":"2021-12-31","value":-2223000}],"freeCashflow":2454000,"dividendsPaid":null,"buybacks":0,"employees":1,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":2292000,"ebit":-4148000,"ebitda":-3242000,"period":"2025-12-31","revenue":893000,"epsBasic":null,"netIncome":-619000,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":-1496000},{"sga":1518000,"ebit":53000,"ebitda":149000,"period":"2025-09-30","revenue":784000,"epsBasic":0.01,"netIncome":152000,"rdExpense":null,"epsDiluted":0.01,"grossProfit":null,"operatingIncome":-830000},{"sga":1551000,"ebit":547000,"ebitda":643000,"period":"2025-06-30","revenue":952000,"epsBasic":0.05,"netIncome":551000,"rdExpense":null,"epsDiluted":0.05,"grossProfit":null,"operatingIncome":-695000},{"sga":1081000,"ebit":-666000,"ebitda":-571000,"period":"2025-03-31","revenue":393000,"epsBasic":-0.06,"netIncome":-653000,"rdExpense":null,"epsDiluted":-0.06,"grossProfit":null,"operatingIncome":-783000},{"sga":879000,"ebit":-1074000,"ebitda":-974000,"period":"2024-12-31","revenue":667000,"epsBasic":null,"netIncome":252000,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":-312000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":-0.05,"netIncome":null,"rdExpense":null,"epsDiluted":-0.05,"grossProfit":547000,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":2.02,"previousClose":2.02,"fiftyTwoWeekHigh":2.95,"fiftyTwoWeekLow":0.98,"fiftyTwoWeekRange":"0.98 - 2.95","fiftyDayAverage":2.13,"twoHundredDayAverage":1.71,"beta":0,"enterpriseValue":19785212,"forwardPE":5.8,"priceToBook":0.87,"priceToSales":6.96,"enterpriseToRevenue":5.9,"enterpriseToEbitda":-14.06,"pegRatio":0,"ebitda":-1407000,"ebitdaMargin":-42,"freeCashflow":1329250,"operatingCashflow":2674000,"totalDebt":4824000,"debtToEquity":17.9,"currentRatio":3.11,"returnOnAssets":-3,"returnOnEquity":0.3,"analystRating":"","recommendationKey":"none","numberOfAnalysts":0,"targetMeanPrice":0,"targetHighPrice":0,"targetLowPrice":0,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":7.4,"institutionHeldPercent":29.6,"sharesOutstanding":11574362,"floatShares":9491787,"sharesShort":56765,"shortRatio":2.44,"shortPercentOfFloat":0.5,"epsTrailing":0.01,"epsForward":0.35,"revenuePerShare":0.29,"bookValue":2.32,"officers":[{"age":49,"name":"Mr. Marlan D. Walker J.D.","title":"Chief Executive Officer"},{"age":51,"name":"Mr. Joseph A. Ziegler","title":"Principal Financial & Accounting Officer"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.therapeuticsmd.com","phone":"561-961-1900"}}